Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
Public ClinicalTrials.gov record NCT01188772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Placebo-Controlled, Dose Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Oral Administration of PSI-7977 in Combination With Pegylated Interferon and Ribavirin in Treatment-Naïve Patients With Chronic HCV Infection Genotype 1, and an Open Label Assessment of PSI-7977 in Patients With HCV Genotypes 2 or 3
Study identification
- NCT ID
- NCT01188772
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 147 participants
Conditions and interventions
Conditions
Interventions
- Sofosbuvir Drug
- Placebo to match sofosbuvir Drug
- PEG Drug
- RBV Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Mar 31, 2011
- Completion
- Apr 30, 2012
- Last update posted
- Apr 20, 2014
2010 – 2012
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Liver and Digestive Specialists | Montgomery | Alabama | — | — |
| Advanced Clinical Research Institute | Anaheim | California | — | — |
| SCTI Research Foundation | Coronado | California | — | — |
| Cedars Sinai Medical Center | Los Angeles | California | — | — |
| Dr. Jay Lalezari | San Francisco | California | — | — |
| Dr. Natalie Bzowej | San Francisco | California | — | — |
| Dr. David Nelson | Gainesville | Florida | — | — |
| Orlando Immunology Center | Orlando | Florida | — | — |
| Gastrointestinal Specialists of Georgia | Marietta | Georgia | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Dr. Mark Sulkowski | Lutherville | Maryland | — | — |
| Liver Research Center Beth Israel Deaconess Medical Center | Boston | Massachusetts | — | — |
| Kansas City Gastroenterology and Hepatology | Kansas City | Missouri | — | — |
| Dr. Bruce Bacon | St Louis | Missouri | — | — |
| North Shore University Hospital | Manhasset | New York | — | — |
| Dr. Ira Jacobson | New York | New York | — | — |
| Mount Sinai School of Medicine | New York | New York | — | — |
| Dr. Jama Darling | Chapel Hill | North Carolina | — | — |
| Dr. Raj Reddy | Philadelphia | Pennsylvania | — | — |
| Columbia Gastroenterology and Liver Associates | Columbia | South Carolina | — | — |
| Dr. Eric Lawitz | San Antonio | Texas | — | — |
| Digestive Disease Institute Virginia Mason Medical Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01188772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2014 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01188772 live on ClinicalTrials.gov.